TRADIPITANT, A NOVEL NEUROKININ-1 RECEPTOR ANTAGONIST, SHOWED CONTINUED IMPROVEMENT IN NAUSEA AND OTHER SYMPTOMS ASSOCIATED WITH GASTROPARESIS IN AN OPEN-LABEL EXTENSION OF A PHASE II CLINICAL TRIAL

Jesse L. Carlin  1     Meredith S. Bagger     Darby S. Madonick     Caleigh Q. Kupersmith     Miren Lopez Lascurain     Changfu Xiao     Gunther Birznieks     Michaela Fisher     Mihael Polymeropoulos    
1 Vanda Pharmaceuticals, Inc., Washington, United States

Session
Functional gastroduodenal disorders

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing